GYRE
GYRE THERAPEUTICS, INC.
Nasdaq Pharmaceutical Preparations Accelerated filer
Smaller reporting company

Key Financials

Gross Profit
$101.9M
↓ 6.4%
Net Income
$9.9M
↓ 44.8%
Revenue
$116.6M
↑ 10.2%
Operating Income
$11.5M
↓ 28.9%
Shareholders' Equity
$106.0M
↑ 67.5%
Total Assets
$166.1M
↑ 32.5%
EPS (Diluted)
$0.02
↓ 60.0%
Total Liabilities
$23.9M
↓ 11.7%

Recent SEC Filings

Form Type Filed Date Link
10-Q 8/7/2026 View on SEC
8-K 8/7/2026 View on SEC
4 8/4/2026 View on SEC
4 8/4/2026 View on SEC
3 8/4/2026 View on SEC
3 8/4/2026 View on SEC
EFFECT 8/3/2026 View on SEC
8-K 7/16/2026 View on SEC
8-K/A 7/15/2026 View on SEC
S-3/A 7/13/2026 View on SEC

Company Information

Field Value
Ticker GYRE
Company Name GYRE THERAPEUTICS, INC.
CIK 1124105
Sector Pharmaceutical Preparations
Industry Accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (858) 284-0115